Ms. Mona Frendo at the Industry, Science and Technology Committee

I'm sorry. I meant section 21.05.

Clause 5 of Bill C-393 would change the current provisions in section 21.05 of the Patent Act by deleting all the references to quantity. It would also add a new proposed section, 21.051, that would put the onus on the authorization holder—the first or the manufacturer who is authorized under Canada's access to medicines regime to export. You would put the onus on that person to bear the responsibility of ensuring that the products that are sent are correctly labelled, as prescribed in the regulations.